GENETWORx COVID-19 Nasal Swab Test Kit Instructions
- June 5, 2024
- GENETWORX
Table of Contents
Your GENETWORx COVID-19 Nasal Swab Test Kit Instructions
Read all directions thoroughly and carefully before you start.
- Before starting step 1, you must go to genetworx.auratracker.org/activation, or scan the QR code on the right to activate your test kit. The lab cannot process your sample if this step is missed.
- Once on the site, you will log into your account and activate your kit by entering the barcode number located on the collection tube.
After activating your test kit, an instructional video will be available for you to view before starting your collection.
WARNING:
- Do not touch or drink the liquid in the collection tube.
- In case of spills/splashes into eyes or skin, immediately wash with lots of water. If any symptoms arise after exposure, call a physician.
SECOND FLAP AFTER OPENING THE FRONT FLAP
What’s inside the kit
**Read all instructions and plan same-day FedEx pickup before you start.
Follow steps 1-18 in order.**
1| | Wash and dry your hands before handling the contents of the collection
kit.
---|---|---
2| | Using a non-smudging blue or black pen/marker, write your first and last
name and date of birth on the collection tube.
3| | Next, using the same non-smudging pen/marker, fill out the Specimen
Confirmation Form.
4| | Screw off the top of the collection tube. Place the cap with the opening
face up on a clean surface. Do not drink the liquid.
5| | Take the swab out of its package. Do not touch the tip of the swab with
your hands, and do not lay it down on any surface.
6| | Hold swab in one hand and collection tube in the other, being careful not
to spill the liquid.
7| | Insert the tip of the swab into one nostril, just until the tip of the
swab is no longer visible.
8| | R otate the swab while gently circling and pressing around the entire
inside edge of your nostril at least 5 times. When finished, take the swab out
of your nostril.
9| | Using the same end of the swab, repeat step 8 in your other nostril.
When finished, take the swab out of your nostril.
10| | Place the swab in the collection tube, so that it is submerged in the
liquid inside the tube.
11| | Break the swab along the pre-scored line by bending it against the
collection tube.
12| | Screw the top of the collection tube back on, ensuring that it is closed
tightly.
13| | Discard the broken top part of the swab.
14| | Wash and dry your hands thoroughly again.
15| | Place the collection tube into the absorbent pad inside the biohazard
specimen bag.
16| | Seal the biohazard specimen bag by closing the zip-lock seal.
17| | Fold the biohazard specimen bag so that it fits into the GENETWORx box
that this at-home kit came in. Place it inside the box, along with your
Specimen Confirmation Form.
18| | Place the shipping box into the FedEx return pack, remove the adhesive
cover strip and seal the FedEx return pack closed.
RETURNING THE TEST KIT
Your test kit must be stored at room temperature and sent back within 24 hours of sample collection.
Please drop your package off before the last pickup of the day. Do not ship
your package late Friday evening, or over the weekend. Do not take it to a
FedEx office.
The pre-addressed FedEx return pack can be mailed to GENETWORx via calling
FedEx to arrange a pickup or by dropping it in a FedEx dropbox.
Visit bit.ly/fedexdropbox online to view FedEx drop box locations and pickup
schedules.
4060 Innslake Drive, Glen Allen, VA 23060
For In Vitro Diagnostic Use Only. For Emergency Use Authorization Only. Rx Only. For Use by Individuals 18 Years or Older.
This product (home collection kit in combination with the authorized test) has
not been FDA cleared or approved but has been authorized for emergency use by
FDA under
a EUA for use by authorized laboratories.
This product has been authorized only for the detection of nucleic acid from SARS-COV-2, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the
declaration that circumstances exist justifying the authorization of emergency
use of in vitro
diagnostics for the detection and/or diagnosis of COVID-19 under Section
564(b)(1) of the Federal, Food, Drug, and Cosmetic Act, 21 U.S.C. §
360bbb-3(b)(1), unless the declaration is terminated or authorization is
revoked sooner.